Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial. (Q39668099)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 June 2016
edit
Language Label Description Also known as
English
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.
scientific article published on 20 June 2016

    Statements

    Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial. (English)
    1 reference
    0 references
    Nick Pavlakis
    1 reference
    Andrew J Martin
    1 reference
    Eric Tsobanis
    1 reference
    Sonia Yip
    1 reference
    Yoon-Koo Kang
    1 reference
    Yung-Jue Bang
    1 reference
    Thierry Alcindor
    1 reference
    Christopher J O'Callaghan
    1 reference
    Margot J Burnell
    1 reference
    Niall C Tebbutt
    1 reference
    Sun Young Rha
    1 reference
    Jeeyun Lee
    1 reference
    Jae-Yong Cho
    1 reference
    Lara R Lipton
    1 reference
    Mark Wong
    1 reference
    Andrew Strickland
    1 reference
    Jin Won Kim
    1 reference
    John R Zalcberg
    1 reference
    John Simes
    1 reference
    David Goldstein
    1 reference
    20 June 2016
    1 reference
    34
    1 reference
    2728-2735
    1 reference
    23
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit